Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: Preliminary findings

Molecular BioSystems

Volumn 9, Issue 6, 2013, Pages 1162-1168

  Cigna, Diego ^a   D'Anna, Claudia ^a   Zizzo, Carmela ^a   Francofonte, Daniele ^a   Sorrentino, Iacopo ^a   Colomba, Paolo ^a   Albeggiani, Giuseppe ^a   Armini, Alessandro ^b   Bianchi, Laura ^b   Bini, Luca ^b   Duro, Giovanni ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; ALPHA-GALACTOSIDASE A, HUMAN; BIOLOGICAL MARKER; CALNEXIN; CHLORIDE CHANNEL; CLIC1 PROTEIN, HUMAN; ENOLASE; GALECTIN 1; PROTEIN 14 3 3; PROTEOME; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 1; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 2; ALPHA GALACTOSIDASE A, HUMAN;

ADULT; BIOSYNTHESIS; CELL PROLIFERATION; DOWN REGULATION; FABRY DISEASE; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; INFLAMMATION; MALE; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PROTEIN FOLDING; PROTEOMICS; SIGNAL TRANSDUCTION; UPREGULATION; ARTICLE; MASS SPECTROMETRY;

14-3-3 PROTEINS; ADULT; ALPHA-GALACTOSIDASE; BIOMARKERS; CALNEXIN; CELL PROLIFERATION; CHLORIDE CHANNELS; DOWN-REGULATION; FABRY DISEASE; FEMALE; GALECTIN 1; GENE EXPRESSION; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; PROTEIN FOLDING; PROTEOME; PROTEOMICS; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR ALPHA; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR BETA; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UP-REGULATION; BIOLOGICAL MARKERS;

EID: 84877756599     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/c3mb25402j     Document Type: Article

References (50)

1. R. O. Brady A. E. Gal R. M. Bradley E. Martensson A. L. Warshaw L. Laster Enzymatic defect in Fabry's disease, Ceramidetrihexosidase deficiency N. Engl. J. Med. 1967 276 1163 1167
2. J. A. Kint Fabry's disease: alpha-galactosidase deficiency Science 1970 167 1268 1269
3. R. J. Desnick, Y. A. Ioannou and C. M. Eng, α-galactosidase A deficiency: Fabry disease, in The Metabolic and Molecular Bases of Inherited Disease, ed., C. R. Scriver, A. L. Beaudet, W. S. Sly, and, D. Valle, McGraw-Hill Professional, New York, 2000, 8th edn, pp. 3733-3774
4. R. J. Hopkin J. Bissler M. Banikazemi L. Clarke C. M. Eng D. P. Germain R. Lemay A. Tylki-Szymanska W. R. Wilcox Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry Pediatr. Res. 2008 64 550 555
5. U. Ramaswami C. Whybra R. Parini G. Pintos-Morell A. Mehta G. Sunder-Plassmann U. Widmer M. Beck Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey Acta Paediatr. 2006 95 86 92
6. Y. A. Zarate R. J. Hopkin Fabry's disease Lancet 2008 372 1427 1435
7. R. J. Desnick, Y. A. Ioannou and C. M. Eng, Alpha-galactosidase A deficiency: Fabry disease, McGraw-Hill Professional, New York, 8th edn, 2001, vol. 1
8. S. Ishii H. H. Chang K. Kawasaki K. Yasuda H. L. Wu S. C. Garman J. Q. Fan Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin Biochem. J. 2007 406 285 295
9. S. Ishii Y. Suzuki J. Q. Fan Role of Ser-65 in the activity of alpha-galactosidase A: characterization of a point mutation (S65T) detected in a patient with Fabry disease Arch. Biochem. Biophys. 2000 377 228 233
10. S. Ishii R. Kase H. Sakuraba Y. Suzuki Characterization of a mutant alpha-galactosidase gene product for the late-onset cardiac form of Fabry disease Biochem. Biophys. Res. Commun. 1993 197 1585 1589
11. J. S. Shen X. L. Meng D. F. Moore J. M. Quirk J. A. Shayman R. Schiffmann C. R. Kaneski Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells Mol. Genet. Metab. 2008 95 163 168
12. P. Rozenfeld E. Agriello N. De Francesco P. Martinez C. Fossati Leukocyte perturbation associated with Fabry disease J. Inherited Metab. Dis. 2009 32 suppl. 1 67 77
13. J. S. Shen X. L. Meng D. F. Moore J. M. Quirk J. A. Shayman R. Schiffmann C. R. Kaneski Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells Mol. Genet. Metab. 2008 95 163 168
14. B. Domon R. Aebersold Mass spectrometry and protein analysis Science 2006 312 212 217
15. H. Leffler S. Carlsson M. Hedlund Y. Qian F. Poirier Introduction to galectins Glycoconjugate J. 2004 19 433 440
16. E. M. Rapoport O. V. Kurmyshkina N. V. Bovin Mammalian galectins: structure, carbohydrate specificity, and functions Biochemistry 2008 73 393 405
17. C. D. Gil D. Cooper G. Rosignoli M. Perretti S. M. Oliani Inflammation-induced modulation of cellular galectin-1 and -3 expression in a model of rat peritonitis Inflammation Res. 2006 55 99 107
18. C. D. Gil M. La M. Perretti S. M. Oliani Interaction of human neutrophils with endothelial cells regulates the expression of endogenous proteins annexin 1, galectin-1 and galectin-3 Cell Biol. Int. 2006 30 338 344
19. G. A. Rabinovich M. M. Iglesias N. M. Modesti L. F. Castagna C. Wolfenstein-Todel C. M. Riera C. E. Sotomayor Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: biochemical and functional characterization J. Immunol. 1998 160 4831 4840
20. C. Blaser M. Kaufmann C. Muller C. Zimmermann V. Wells L. Mallucci H. Pircher Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells Eur. J. Immunol. 1998 28 2311 2319
21. E. Zuniga G. A. Rabinovich M. M. Iglesias A. Gruppi Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis J. Leukocyte Biol. 2001 70 73 79
22. M. La T. V. Cao G. Cerchiaro K. Chilton J. Hirabayashi K. Kasai S. M. Oliani Y. Chernajovsky M. Perretti A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation Am. J. Pathol. 2003 163 1505 1515
23. D. Cooper L. V. Norling M. Perretti Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow J. Leukocyte Biol. 2008 83 1459 1466
24. C. D. Gil D. Cooper G. Rosignoli M. Perretti S. M. Oliani Inflammation-induced modulation of cellular galectin-1 and -3 expression in a model of rat peritonitis Inflammation Res. 2006 55 99 107
25. G. B. Biancini C. S. Vanzin D. B. Rodrigues M. Deon G. S. Ribas A. G. Barschak V. Manfredini C. B. Netto L. B. Jardim R. Giugliani C. R. Vargas Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy Biochim. Biophys. Acta 2012 1822 2 226 232
26. C. D. Gil C. E. Gullo S. M. Oliani Effect of exogenous galectin-1 on leukocyte migration: modulation of cytokine levels and adhesion molecules Int. J. Clin. Exp. Pathol. 2010 4 74 84
27. P. Steinacker A. Aitken M. Otto 14-3-3 proteins in neurodegeneration Semin. Cell. Dev. Biol. 2011 22 696 704
28. T. T. Wong L. Zhou J. Li L. Tong S. Z. Zhao X. R. Li S. J. Yu S. K. Koh R. W. Beuerman Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication Invest. Ophthalmol. Visual Sci. 2011 10 7385 7391
29. X. Q. Chen J. G. Chen Y. Zhang W. W. Hsiao A. C. Yu 14-3-3gamma is upregulated by in vitro ischemia and binds to protein kinase Raf in primary cultures of astrocytes Glia 2003 42 4 315 324
30. Y. Dong R. Zhao X. Q. Chen A. C. Yu 14-3-3gamma and neuroglobin are new intrinsic protective factors for cerebral ischemia Mol. Neurobiol. 2010 41 2-3 218 231
31. W. H. Fong H. D. Tsai Y. C. Chen J. S. Wu T. N. Lin Anti-apoptotic actions of PPARgamma against ischemic stroke Mol. Neurobiol. 2010 41 2-3 180 186
32. H. Haimoto Y. Takahashi T. Koshikawa H. Nagura K. Kato Immunohistochemical localization of gamma-enolase in normal human tissues other than nervous and neuroendocrine tissues Lab. Invest. 1985 52 3 257 263
33. C. M. Buckner T. M. Calderon D. W. Willams T. J. Belbin J. W. Berman Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS Cell. Immunol. 2011 267 2 109 123
34. T. Ingebrigtsen B. Romner Biochemical serum markers of traumatic brain injury J. Trauma 2002 52 4 798 808
35. E. Chevet J. Smirle P. H. Cameron D. Y. Thomas J. J. Bergeron Calnexin phosphorylation: linking cytoplasmic signalling to endoplasmic reticulum lumenal functions Semin. Cell. Dev. Biol. 2010 21 5 486 490
36. J. Groenendyk M. Michalak Endoplasmic reticulum quality control and apoptosis Acta Biochim. Pol. 2005 52 381 395
37. M. Michalak E. F. Corbett N. Mesaeli K. Nakamura M. Opas Calreticulin: one protein, one gene, many functions Biochem. J. 1999 344 281 292
38. A. Zuppini J. Groenendyk L. A. Cormack G. Shore M. Opas R. C. Bleackley M. Michalak Calnexin deficiency and endoplasmic reticulum stress-induced apoptosis Biochemistry 2002 41 8 2850 2858
39. B. Boettner L. Van Aelst The role of Rho GTPases in disease development Gene 2002 286 155 174
40. Y. Nishimura B. Bereczky K. Yoshioka S. Taniguchi K. Itoh A novel role of Rho-kinase in the regulation of ligand-induced phosphorylated EGFR endocytosis via the early/late endocytic pathway in human fibrosarcoma cells J. Mol. Histol. 2011 42 5 427 442
41. D. N. Hebert M. Molinari In and out of the ER: protein folding, quality control, degradation, and related human diseases Physiol. Rev. 2007 87 1377 1408
42. S. Ishii Pharmacological chaperone therapy for Fabry disease Proc. Jpn. Acad., Ser. B 2012 88 1 18 30
43. H. Askari C. R. Kaneski C. Semino-Mora P. Desai A. Ang D. E. Kleiner L. T. Perlee M. Quezado L. E. Spollen B. A. Wustman R. Schiffmann Cellular and tissue localization of globotriaosylceramide in Fabry disease Virchows Arch. 2007 451 823 834
44. M. Alfadhel S. Sirrs Enzyme replacement therapy for Fabry disease: some answers but more questions Ther. Clin. Risk Manage. 2011 7 69 82
45. B. R. Oakley D. R. Kirsch N. R. Morris A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels Anal. Biochem. 1980 105 2 361 363
46. D. F. Hochstrasser M. G. Harrington A. C. Hochstrasser M. J. Miller C. R. Merril Methods for increasing the resolution of two-dimensional protein electrophoresis Anal. Biochem. 1988 173 2 424 435
47. P. Sinha J. Poland M. Schnölzer T. Rabilloud A new silver staining apparatus and procedure for matrix-assisted laser desorption/ionization-time of flight analysis of proteins after two-dimensional electrophoresis Proteomics 2001 1 7 835 840
48. U. Hellman C. Wernstedt J. Góñez C. H. Heldin Improvement of an "In-Gel" digestion procedure for the micropreparation of internal protein fragments for amino acid sequencing Anal. Biochem. 1995 224 1 451 455
49. V. Soskic M. Görlach S. Poznanovic F. D. Boehmer J. Godovac-Zimmermann Functional proteomics analysis of signal transduction pathways of the platelet-derived growth factor beta receptor Biochemistry 1999 38 6 1757 1764
50. F. Gharahdaghi C. R. Weinberg D. A. Meagher B. S. Imai S. M. Mische Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity Electrophoresis 1999 20 3 601 605